Skip to main content
. Author manuscript; available in PMC: 2023 Sep 28.
Published in final edited form as: ASAIO J. 2022 Sep 28;68(6):859–864. doi: 10.1097/MAT.0000000000001575

Table VII.

Incidence of Adverse Events in ≤ 8 and >8 Day Exchange Groups

Event ≤ 8 Days (n=40; 343 days) EPPD >8 days (n=21; 564 days) EPPD P value
AKI 18 (45.0%) - 7 (33.3%) - 0.42
Dialysis 13 (32.5%) - 6 (28.6%) - 1.00
Neurological dysfunction 4 (10.0%) 0.01 1 (4.8%) 0.002 0.65
IND 1 (2.5%) 0.002 1 (4.8%) 0.002 1.00
HND 3 (7.5%) 0.009 0 (0.0%) 0.00 0.54
GI bleeding 4 (10.0%) 0.01 9 (42.9%) 0.016 0.01
Anticoagulation 17 (42.5%) - 17 (81.0%) - 0.01

EPPD, event per patient per day; AKI, acute kidney injury; IND, ischemic neurological dysfunction; HND, hemorrhagic neurological dysfunction; GI bleeding; gastrointestinal bleeding;